UL
Uri Landesman
10% Owner

Uri Landesman insider trades: Navidea Biopharmaceuticals (NAVB) stock buys and sales

10% Owner, Navidea Biopharmaceuticals Last trade Sep 2, 2014 6 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
6
Open-market trades
since 2013
2
Companies
last trade 2014

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Uri reports to the SEC

Open-market buys and sales

6 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 2, 2014NAVB↓ Sell$82K
Jun 30, 2014ECTE↑ Buy$145K
Jun 26, 2014ECTE↑ Buy$38K
Jun 24, 2014ECTE↑ Buy$37K
Dec 10, 2013ECTE↑ Buy$153K
Dec 10, 2013ECTE↑ Buy$38K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Uri Landesman's insider trades

Uri Landesman is a 10% owner of Navidea Biopharmaceuticals (NAVB). Since Dec 10, 2013, Uri has reported 5 open-market purchases worth $411K and 1 sale worth $82K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include other transactions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NAVB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.